InChI=1S/C22H32O4/c1- 2- 3- 10- 15- 20(23) 17- 12- 8- 9- 13- 18- 21(24) 16- 11- 6- 4- 5- 7- 14- 19- 22(25) 26/h3,5- 13,17- 18,20- 21,23- 24H,2,4,14- 16,19H2,1H3,(H,25,26) /p- 1/b7- 5- ,9- 8+,10- 3- ,11- 6- ,17- 12- ,18- 13+/t20- ,21- /m1/s1 |
CRDZYJSQHCXHEG-HBMALMRFSA-M |
[O-]C(CC/C=C\C/C=C\C[C@H](\C=C\C=C\C=C/[C@@H](C/C=C\CC)O)O)=O |
|
(4Z,7Z,10R,11E,13E,15Z,17R,19Z)- 10,17- dihydroxydocosa- 4,7,11,13,15,19- hexaenoate
|
(4Z,7Z,10R,11E,13E,15Z,17R,19Z)- 10,17- dihydroxydocosahexaenoate
|
ChEBI
|
10(R),17(R)- dihydroxydocosa- 4Z,7Z,11E,13E,15Z,19Z- hexaenoate
|
ChEBI
|
aspirin-triggered neuroprotectin D1(1−)
|
ChEBI
|
AT-(NPD1/PD1)(1−)
|
ChEBI
|
AT-NPD1(1−)
|
ChEBI
|
AT-PD1(1−)
|
ChEBI
|
|